Please login to the form below

Not currently logged in
Email:
Password:

Roche's HIV-1 test approved in Europe

Roche has announced that it has received CE Mark certification for its dual-target HIV-1 test

Roche has announced that it has received CE Mark certification for its dual-target HIV-1 test.

This certification allows the product, which amplifies and detects two separate regions of the HIV-1 genome simultaneously, to be sold for clinical use in the European Union. According to the company, this provides reliable test results even when mutations are present.

"HIV mutations are a serious problem. Because it is impossible to predict when these mutations will occur, we have designed this test to detect all HIV-1 (Group M and O) strains," said Daniel O'Day, president and CEO of Roche Molecular Diagnostics. "This innovative fully-automated solution will provide reliable results for laboratories and physicians to more confidently and efficiently treat HIV-1 patients undergoing therapy."

HIV is a retrovirus that infects cells of the human immune system. In the early stages of infection, the person experiences no symptoms. Untreated, HIV will usually develop into AIDS within 10 to 15 years.

Roche's test is highly sensitive and can detect both very low and very high levels of the virus, a key indicator of the need for more or less aggressive treatment.
 

16th December 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wordbird

Wordbird is a healthcare communications agency with creative, compelling copy at its heart....

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics